NYSEMKT: OSTXOs Therapies Inc Stock Ownership - Who owns Os Therapies?
Insider buying vs selling
Have Os Therapies Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shalom Auerbach | 10% Owner | 2025-05-07 | 82,000 | $2.00 | $163.92kSell |
| Shalom Auerbach | 10% Owner | 2025-04-10 | 10,000 | $1.39 | $13.90kSell |
| Shalom Auerbach | 10% Owner | 2025-04-09 | 50,012 | $1.35 | $67.67kSell |
| Shalom Auerbach | 10% Owner | 2025-02-27 | 225,000 | $1.64 | $369.00kSell |
| Shalom Auerbach | 10% Owner | 2025-02-14 | 100,000 | $2.84 | $284.30kSell |
| Shalom Auerbach | 10% Owner | 2025-01-15 | 16,720 | $6.74 | $112.61kSell |
OSTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OSTX insiders and whales buy or sell their stock.
OSTX Shareholders
What type of owners hold Os Therapies Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Shalom Auerbach | 9.57% | 2,687,570 | $4.89M | Insider |
| Paul A. Romness | 8.80% | 2,473,000 | $4.50M | Insider |
| Theodore F. Search | 1.62% | 455,835 | $829.62k | Insider |
| John Ciccio | 1.62% | 455,835 | $829.62k | Insider |
| CM Management LLC | 1.07% | 300,000 | $546.00k | Institution |
| Colin Goddard | 0.80% | 225,179 | $409.83k | Insider |
| Robert Petit | 0.71% | 200,000 | $364.00k | Insider |
| Christopher P. Acevedo | 0.36% | 100,000 | $182.00k | Insider |
| Blackrock Inc | 0.13% | 37,507 | $68.26k | Institution |
| Ingalls Snyder LLC | 0.13% | 36,676 | $66.75k | Institution |
OSTX vs Biotech Stocks
Os Therapies Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.